Clinical trial results
Clinical trial
results
Research Sponsor: AstraZeneca AB
Drug Studied: abediterol
National Clinical Trial #: NCT02777827
Protocol #: D6540C00002
Study Date: June 2016 to November 2016
Short Study Title: A study in participants with asthma to learn more
about how abediterol acts in the body and if the
participants taking it have medical problems
Thank you!
As a clinical study participant, you belong to a large community of participants
around the world. You help researchers answer important health questions
and discover new medical treatments.
Thank you for taking part in the clinical study for the drug abediterol.
This drug is being developed to treat asthma. You and all of the other
participants helped researchers learn how abediterol affects the body
and acts in the body, how much of abediterol reaches the blood, and
if abediterol causes medical problems.
AstraZeneca AB, the sponsor of this study, thanks you for your help
and thinks it is important for you to know the results of your study. An
independent non-profit organization called CISCRP prepared this summary
of the study results for you with the help of a medical writing organization.
We hope it helps you understand and feel proud of your important role in
medical research. If you have questions about the results, please speak with
the doctor or staff at your study site.
1